Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Learn essential tips for setting up a zero based budget. This approach ensures every dollar has a purpose, leading to better financial management.
17,749 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
QYLD offers a headline 12% yield through its covered-call strategy, yet 10-year total returns lag the Nasdaq-100 and ...
XRP tests the $1.40 support as bulls fight for momentum. Here are the three signals shaping its path this week.
Modine Manufacturing faced a pivotal Q4 print as investors eye margin recovery and cash flow. The stock surged ahead ...
Dogecoin has fallen under the 10-cent threshold amid a broad risk-off in crypto markets. With no single catalyst, tra...
Investors confront a cooling AI rally as Rambus faces growth deceleration and valuation pressures, signaling a potent...
A little-known micro-market has outpaced the broader S&P 500 by roughly fivefold in 30 days, highlighting AI hardware...
A little-known micro-cap trading under $30 is drawing renewed investor interest as quarterly results show improving p...
Vertex Pharmaceuticals is being pitched as a durable cash-flow king for patient investors. This piece analyzes the ca...
Portugal and Austria won two Western seats on the U.N. Security Council, edging out Germany after a tight vote. The m...
XRP is at a pivotal juncture in 2026. Grok AI lays out a bullish path, while the mystery around Elon Musk's stance ke...
Investors targeting higher income are turning to closed-end funds trading at discounts to NAV, seeking a compelling y...